Conference Program Home
My Program
All Times EDT
Legend:
CC = Walter E. Washington Convention Center M = Marriott Marquis Washington, DC
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
243
|
Tue, 8/9/2022,
8:30 AM -
10:20 AM
|
CC-144A
|
|
Operational Considerations in Clinical Trials — Contributed Papers
|
|
Biopharmaceutical Section
|
|
Chair(s): Susan Mayo, Food and Drug Administration, Center for Drug Evaluation
|
|
8:35 AM
|
Sample Size Re-Estimation: Timing, Decision Rule, and Study Power
David Li, Eisai; Yan Li , Washington University School of Medicine
|
|
8:50 AM
|
Statistical Power of Survival Trials Weakened by COVID-19 Pandemic
Ping Xu, Merck & Co.; Gregory T Golm, Merck & Co.
|
|
9:05 AM
|
Efficient Parameter Estimation in Seamless Adaptive Group Sequential Designs
Krishna Padmanabhan, Cytel; Cyrus Mehta, Cytel; Lingyun Liu, Vertex Inc; Pranab Ghosh, Pfizer Inc
|
|
9:20 AM
|
Power and Sample Size Calculation for Weighted Log-Rank Tests in Group Sequential Trials
Kaifeng Lu, BeiGene
|
|
9:35 AM
|
Empirical Power of Adaptive Long-Term Restricted Mean Survival Time-Based Tests in Contemporary Phase III Cancer Immunotherapy Studies
Miki Horiguchi, Dana-Farber Cancer Institute; Hajime Uno, Dana-Farber Cancer Insitute
|
|
9:50 AM
|
Statistical Comparison of Waterfall Plots in Oncology Drug Development
Mo Huang, Merck & Co., Inc.; Linda Sun, Merck & Co, Inc.; Cong Chen, Merck & Co., Inc.
|
|
10:05 AM
|
Floor Discussion
|
|
